Activation of caspase-mediated apoptosis is reported to be a hallmark of both granzyme B- and Fas- mediated pathways of killing by cytotoxic T lymphocytes (CTL); however, the kinetics of caspase activation remain undefined due to an inability to monitor target cell-specific apoptosis in real time. We have overcome this limitation by developing a novel biosensor assay that detects continuous, protease specific activity in target cells. Biosensors were engineered from a circularly-permuted luciferase, linked internally by either caspase 3/7 or granzyme B/caspase 8 cleavage sites, thus allowing activation upon proteolytic cleavage by the respective proteases. Co-incubation of murine CTL with target cells expressing either type of biosensor led to a robust luminescent signal within minutes of cell contact. The signal was modulated by the strength of TCR signaling, the ratio of CTL/target cells, and the type of biosensor utilized. Additionally, the luciferase signal at 30 minutes correlated with target cell death, as measured by 51Cr release assay. The rate of caspase 3/7 biosensor activation was unexpectedly rapid following granzyme B compared to Fas-mediated signal induction in murine CTL; the latter appeared gradually after a 90 minute delay in perforin or granzyme B deficient CTL. Remarkably, the Fas dependent, caspase 3/7 biosensor signal induced by perforin-deficient human CTL was also detectable after a 90 minute delay when measured by re-directed killing. Thus we have utilized a novel, real-time assay to demonstrate the distinct pattern of caspase activation induced by granzyme B versus Fas in human and murine CTL.